Analysts Set The Cooper Companies, Inc. (NASDAQ:COO) PT at $81.85

The Cooper Companies, Inc. (NASDAQ:COO) has been assigned a consensus recommendation of “Hold” from the sixteen brokerages that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation, seven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $81.8462.

A number of equities analysts recently issued reports on the stock. Needham & Company LLC decreased their target price on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a report on Wednesday, May 27th. BNP Paribas Exane lowered their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Mizuho set a $85.00 target price on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Finally, Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th.

Institutional Investors Weigh In On Cooper Companies

Several hedge funds have recently modified their holdings of the stock. State Street Corp lifted its stake in Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after buying an additional 207,195 shares in the last quarter. Wellington Management Group LLP boosted its stake in Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD grew its position in Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. Sustainable Growth Advisers LP raised its stake in Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after purchasing an additional 747,476 shares during the period. Finally, Franklin Resources Inc. lifted its holdings in shares of Cooper Companies by 108.2% in the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock valued at $329,646,000 after purchasing an additional 2,089,763 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Trading Down 1.9%

COO opened at $71.71 on Monday. The stock has a market capitalization of $13.99 billion, a PE ratio of 60.77, a P/E/G ratio of 1.91 and a beta of 0.84. The firm’s fifty day moving average price is $66.24 and its 200 day moving average price is $72.58. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, research analysts expect that Cooper Companies will post 4.63 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.